Correction: International Regulatory Collaboration on the Analysis of Nitrosamines in Metformin-Containing Medicines

Affiliations

• ¹ Office of Testing and Research, Office of Pharmaceutical Quality, Food and Drug Administration, 645 S. Newstead Ave., St. Louis, MO, 63110, USA. David.Keire@fda.hhs.gov.
• ² European Medicines Agency, Domenico Scarlattilaan 6, 1083 HS, Amsterdam, The Netherlands.
• ³ Bayerisches Landesamt Für Gesundheit Und Lebensmittelsicherheit, LGL, Veterinärstr. 2, 85764, Oberschleissheim, Germany.
• ⁴ Chemisches Und Veterinäruntersuchungsamt Karlsruhe, CVUA Karlsruhe, Weißenburger Str. 3, 76187, Karlsruhe, Germany.
• ⁵ Institute for Pharmaceutical and Applied Analytics - InphA GmbH, Emil-Sommer-Strasse 7, 28329, Bremen, Germany.
• ⁶ Schweizerisches Heilmittelinstitut (Biol. & Pharm.), OMCL Swissmedic, Hallerstrasse 7, 3012, Bern, Switzerland.
• ⁷ National Medicines Institute, NIL, 30/34 Chelmska Street, 00725, Warsaw, Poland.
• ⁸ Centre for Health Protection, National Institute for Public Health and the Environment (RIVM), Antonie van Leeuwenhoeklaan 9, 3721 MA, Bilthoven, Utrecht, The Netherlands.
• ⁹ Health Canada, 2301 Midland Avenue, Room 200-59, Toronto, M1P 4R7, Canada.
• ¹⁰ Health Sciences Authority, 11 Outram Road, Bukit Merah, 169078, Singapore.
• ¹¹ TGA Laboratories, 136 Narrabundah Lane, Symonston, Canberra, A.C.T 2606, Australia.
• ¹² European Directorate for the Quality of Medicines & HealthCare, 7 Allée Kastner CS 30026, 67081, Strasbourg, France.